PMID: 6161371Nov 1, 1980Paper

Murine T cell Ia antigens: specificity Iat.46 maps in I-J to I-E chromosomal segment of H-2 complex

Proceedings of the National Academy of Sciences of the United States of America
C E Hayes, J M Maier

Abstract

An alloantiserum was prepared in C57BL/10 mice hyperimmunized with concanavalin A-stimulated B10.HTG thymocytes. Absorption with separated B10.A(3R)B and T lymphocytes, followed by titration on these cell types, revealed a new I-region controlled T-cell specificity, Iat.46. The determinant is present on a subpopulation of mature peripheral T cells but not on B lymphocytes, thymocytes, or bone marrow cells. It is also observed using (A.TH X B10.HTT)F1 anti-A.TL antiserum on B10.A(3R) T lymphocytes. The k and d haplotypes are fully crossreactive with regard to Iat.46 expression. B10.HTT, C57BL/10, and BSVS do not carry the Iat.46-encoding allele. Moreover, Iat.46 is not a determinant formed by I-A--I-E gene complementation. The Iat.46-controlling gene, Ia-8, may be positioned to the left of the B10.HTT crossover and to the right of the B10.A(3R) recombinational event. Thus, this determinant may be considered either to represent complexity within the I-J subregion or to demarcate a new I subregion between I-J and I-E.

References

Jan 1, 1976·The Journal of Experimental Medicine·C DavidD Shreffler
Jan 1, 1976·Transplantation Reviews·C S David
Apr 1, 1978·The Journal of Experimental Medicine·K Okuda, C S David
Sep 1, 1978·The Journal of Experimental Medicine·C E Hayes, F H Bach
Oct 1, 1978·The Journal of Experimental Medicine·P P JonesH O McDevitt
Dec 1, 1979·The Journal of Experimental Medicine·J E SwierkoszJ W Kappler
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·D C ShrefflerJ E Niederhuber
Mar 1, 1978·The Journal of Experimental Medicine·R M ZinkernagelJ Klein
Jul 1, 1979·The Journal of Experimental Medicine·T L Delovitch, B H Barber
Sep 1, 1976·The Journal of Experimental Medicine·K OkumuraL A Herzenberg
Sep 1, 1976·The Journal of Experimental Medicine·D B MurphyH O McDevitt
Jan 21, 1972·Science·B Benacerraf, H O McDevitt
Dec 1, 1974·The Journal of Experimental Medicine·D ArmerdingD H Katz
Nov 1, 1974·The Journal of Experimental Medicine·J A FrelingerD C Shreffler
Feb 1, 1980·The Journal of Experimental Medicine·C E Hayes, F H Bach
Mar 1, 1980·The Journal of Experimental Medicine·W P LafuseC S David
Sep 1, 1964·The Journal of Experimental Medicine·A E REIF, J M ALLEN

❮ Previous
Next ❯

Citations

Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C E Hayes, D A Hullett
Apr 1, 1985·Immunological Reviews·C E Hayes, K K Klyczek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
C E Hayes, D A Hullett
Proceedings of the National Academy of Sciences of the United States of America
E StockertK Itakura
Proceedings of the National Academy of Sciences of the United States of America
Z IkezawaJ Klein
© 2021 Meta ULC. All rights reserved